Grants for For profit organizations other than small businesses - Federal

This program provides funding to tribal organizations and institutions to improve justice system facilities and enhance corrections operations in Native American communities across the United States.

This funding opportunity supports innovative projects that develop advanced high-voltage direct current technologies to enhance the resilience and sustainability of the U.S. energy grid, targeting domestic entities and collaborations focused on improving power transmission systems.

This grant provides funding for researchers developing innovative electronic, photonic, and magnetic devices to advance technology in areas like communication, healthcare, and energy.

The National Cancer Institute (NCI) intends to issue the U54 Specialized Programs of Research Excellence in Cancer Health Disparities and Minority Health (CHD-MH SPORE) notice of funding opportunity (NOFO). The program will support a network of multidisciplinary, multi-institutional U54 CHD-MH SPOREs, which are multi-project awards uniquely focused on health disparities and/or minority health translational research for improved prevention, early detection, diagnosis, and treatment of cancer in populations who are underserved. U54 CHD-MH SPOREs can investigate more than one cancer type in underserved populations, including groups of highly related cancers (e.g., gastrointestinal or head and neck). The research supported through this program must be translational and must stem from research on human biology, addressing the interplay of various determinants of health with the biology of the disease. U54 CHD-MH SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant, which may include a clinical trial. This Notice of Intent to Publish is being provided to allow sufficient time for applicants to develop strong applications. The NOFO is expected to be published in late winter 2024 with only one expected application due date in late September 2024.

This funding opportunity provides financial support to state and local governments, public utilities, and agencies for the procurement and use of low-carbon products made from captured carbon emissions, promoting sustainable practices and environmental benefits.

This funding opportunity provides financial support for universities, nonprofits, and government entities to develop and operationalize advanced ocean and coastal observing technologies that enhance data collection and environmental monitoring.

This funding opportunity provides financial support for organizations to host conferences and workshops that promote research integrity and ethical practices in research across various disciplines.

This funding opportunity provides financial support to U.S. companies and organizations to boost domestic production capabilities for critical defense materials and technologies, ensuring national security and resilience in the industrial base.

This funding opportunity provides financial support to domestic entities that own or operate coal-fired power plants, enabling them to recommission, modernize, or retrofit their facilities to enhance grid reliability and support energy needs in rural communities.

This funding opportunity supports K-12 schools and organizations in Washington and Oregon to create hands-on environmental education projects that promote climate resilience and incorporate Indigenous Knowledge.

USAID/Philippines Sources Sought Notice Market Research for USAID/Philippines Biodiversity and Climate Change Activity ISSUING DATE: May 26, 2023 CLOSING DATE: June 26, 2023, 2:00 PM (Philippine time) The United States Agency for International Development's Mission to the Philippines (USAID/Philippines) is developing a new five-year Activity on biodiversity conservation that will address the related issues of biodiversity loss and climate change. The Activity will improve enabling environments for strengthening key institutions, and leveraging private sector investments and financing for nature-based conservation, adaptation, and mitigation. Subject to availability of funds, USAID/Philippines anticipates this activity will be implemented for five (5) years. Through this Sources Sought Notice (SSN), USAID/Philippines is seeking to learn the capabilities, interest, and recommendations from all relevant parties within the Philippines and internationally, e.g., US or non-US nongovernmental organizations, universities, consortia, and for-profit entities. Respondents from all sectors including non-government, non-profit, for profit, academic and research institutions, and civil society are encouraged to respond to this SSN. IMPORTANT: Please open the "Related Documents" tab for the full Sources Sought Notice.

This funding opportunity seeks innovative research proposals from various entities, including businesses and universities, to develop groundbreaking technologies for national security, focusing on areas like novel materials, quantum computing, and artificial intelligence.

The United States Agency for International Development (USAID) Bureau for Humanitarian Assistance (BHA) is seeking applications for funding from qualified entities to implement programming and activities for Humanitarian Capacity and System Strengthening. BHA is soliciting applications to support programs that focus on improving policies, practice, and standards in humanitarian response through increased coordination among key stakeholders, technical and policy engagement with relevant global actors, innovative and effective approaches to delivering and financing humanitarian assistance, as well as for thematic and operational issues improving humanitarian response to affected populations. This also includes enhancing humanitarian actors ability to respond to humanitarian crises by developing tools and methodologies that contribute to greater understanding of key issues affecting people in crises and humanitarian actors responding to their needs. BHA expects successful applicants to work with BHA and other relevant stakeholders to make new policies, practices, tools, methodologies and innovations available to the wider humanitarian community, where appropriate. Activities are grouped by objective. For the first round of applications, BHA will consider applications focused on only one objective. Should an applicant wish to submit an application for more than one objective, the applicant must do so by submitting separate applications for each objective. Subject to the availability of funds, BHA intends to have more than one round of applications under this APS. BHA intends to award predominantly cooperative agreements, but reserves the right to award any other form of assistance agreement. For the first round of applications, BHA anticipates that the total amount of each award will not exceed $3 million over a two-year period of performance and interested applicants may submit applications for lesser amounts. BHA may amend this APS to increase the funding available for this APS, add or revise program objectives, and/or add additional rounds of applications. USAID will post amendments or addenda to the BHA website and Grants.gov (through which organizations may sign up to receive notifications of changes). The Bureau for Humanitarian Assistance (BHA) has summarized and addressed the questions that BHA received on the subject Annual Program Statement (Funding Opportunity number 720BHA21APS00001) in a response document that is attached in the related documents tab. In addition, BHA has revised the APS to address the questions received. BHA did not respond to comments received on the APS individually.

This program provides funding for U.S.-based researchers and institutions to develop innovative technologies and processes that enhance environmental sustainability and resilience while promoting efficient resource use.

This competition provides funding and support for teams developing innovative high-temperature seismic sensors to improve geothermal energy monitoring and enhance the understanding of subsurface conditions.

Key aspects of the TSA: Multidisciplinary Collaboration: The success of the project should depend on the unique skills and perspectives of each partner. The application must clearly define the synergistic components that will facilitate and accelerate progress in melanoma in a way that could not be accomplished through independent efforts. The plans for interactions among all PIs and institutions involved must be clearly articulated. Collectively, the members of the research team should represent the appropriate diversity of expertise necessary for addressing the proposed research question. Participating institutions must be willing to resolve potential intellectual and material property issues and remove institutional barriers to achieving high levels of cooperation. The following components of the proposed multidisciplinary collaboration are encouraged but not required: It is strongly encouraged that the research team has a least one investigator, key personnel, or consultant who can provide input on the ultimate utility/applicability (short- or long-term) of the anticipated outcome(s) to the melanoma field and/or patient care. The inclusion of an early-career investigator is encouraged. An early-career investigator is defined as an independent, early-career researcher or physician-scientist within 7 years of receiving their first faculty appointment by the time of the full application deadline. Investigators in mentored positions, (e.g., postdoctoral fellows) are not eligible to be named as a PI on a TSA application. The inclusion of a military and/or U.S. Department of Veterans Affairs (VA) investigator is encouraged. A military or VA investigator is defined as an investigator who is active-duty, active reserve, active duty detailed to agencies outside of the Department of Defense (DOD), civilian DOD investigators, or an investigator at a VA research facility. If included as PI on the research team, the military/VA investigator should have a substantial role in the research and should not be included only for access to active-duty military and/or VA populations. Impact: The application must articulate the impact the proposed work, including basic research, will have on melanoma research and/or patient care. Outcomes from this award are expected to expedite the advancement of promising ideas toward clinical applications and/or improve the current state of the science/technology in the melanoma field. The proposed research must relate to at least one of the FY24 MRP Focus Areas in Section II.A.1. Preliminary Data Required: Applications must include preliminary data to support feasibility of the study. However, these data do not necessarily need to be derived from melanoma studies. Any unpublished, preliminary data presented should originate from the laboratory of at least one of the PIs or other member(s) of the research team.

This funding opportunity supports the establishment of a Coordinating Center to enhance diversity in the aging research workforce through targeted undergraduate education initiatives.

This program provides funding to a variety of organizations to create experiential learning opportunities in emerging technology fields, helping individuals from diverse backgrounds gain skills and transition into STEM careers.

demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the best and brightest in their field(s) through extraordinary creativity, vision, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and must exhibit strong potential for future leadership in breast cancer research.As the intent of the Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the individual named as the Principal Investigator (PI) in the application to go beyond conventional thinking in their field and the innovative contribution that the PI can make toward ending breast cancer. The application should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention.Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award. Individuals from other disciplines who apply novel concepts to breast cancer are encouraged to submit.The PI is encouraged to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. The PIs research team must include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be independent of their employment, and they may not be employees of any organizations participating in the application. The consumer advocates should have a high level of knowledge of current breast cancer issues and the appropriate background and/or training in breast cancer research to contribute to the project. Their role should be focused on providing objective input throughout the research effort and its potential impact for individuals with, or at risk for, breast cancer.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 BCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public. Collaborations between researchers at military or Veteran institutions and non-military institutions are strongly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the partners bring to the research effort, ultimately advancing cancer research that is of significance to the Warfighter, military Families, and the American public.Clinical trials are allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes: (1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 Era of Hope Scholar Award should not exceed $3.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $5.4M to fund approximately one Era of Hope Scholar Award application. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding opportunity provides financial support for research and evaluation projects aimed at improving forensic science practices and their impact on the criminal justice system across the United States, targeting a wide range of eligible organizations including governments, educational institutions, and nonprofits.